menu
Over 80 firms are involved in providing antibody drug discovery-related services; whereas close
Over 80 firms are involved in providing antibody drug discovery-related services; whereas close
Over 80 firms are involved in providing antibody drug discovery-related services; whereas close

Over 80 firms are involved in providing antibody drug discovery-related services; whereas close

Accordingto experts in this field, the industry is investigating antibodies againstnovel targets which are expected to drive the market in the coming years. Infact, many service provider and platform provider companies are offeringsupport to the medical research community in order to develop an appropriateintervention to treat the illness caused by the SARS-CoV-2 virus.

 

To order this 500+ page report, which features 120+ figuresand 140+ tables, please visit this link

 

The USD 6.5billion (by 2030) financial opportunity within the antibody discovery services markethas been analyzed across the following segments:

§ Steps Involved in theAntibody Discovery Process

  • Antigen Designing
  • Hit Generation
  • Lead Selection
  • Lead Optimization
  • Lead Characterization

 

§ Antibody DiscoveryMethod Used

  • Phage Display
  • Hybridoma
  • Transgenic Animal
  • Yeast Display
  • Single Cell
  • Others

 

§ Nature of AntibodyGenerated

  • Humanized
  • Human
  • Chimeric
  • Murine

 

§ Key GeographicalRegions 

  • North America
  • Europe
  • Asia Pacific and Rest of the World

 

The USD 5.9billion (by 2030) financial opportunity within the antibody discovery platformsmarket has been analysed across the following segments:

§ Type of Payment

  • Upfront Payments
  • Milestone Payments

 

§ Key GeographicalRegions 

  • North America
  • Europe
  • Asia Pacific

 

 

TheAntibodyDiscovery: Services and Platforms Market (3rd Edition), 2020-2030 report features thefollowing companies, which we identified to be key players in this domain:

§ Abzena

§ Abwiz Bio

§ Aragen Bioscience

§ BIOTEM

§ ChemPartner

§ Creative Biolabs

§ Distributed Bio

Press Release:Variation 3 (Format 4)

 

§ Harbour BioMed

§ HD Biosciences

§ ImmunoPrecise Antibodies

§ Integral Molecular

§ Kymab

§ LakePharma

§ Ligand Pharmaceuticals

§ MorphoSys

§ PX’Therapeutics

§ Syd Labs

§ Viva Biotech

§ Wuxi Biologics

 

Table of Contents

 

1. Preface

2. Executive Summary


3. Introduction

4. Antibody Discovery Process and Methods

 

5. Antibody Discovery Service Providers: Current Market Landscape

 

6. Company Competitiveness Analysis

7. Company Profiles: Antibody Discovery Service Providers

8. Antibody Discovery Technologies: Current Market Landscape

9. Technology Competitiveness Analysis

10. Company Profiles: Antibody Discovery Platform Providers

11. Regional Capability Analysis

 

12. Partnerships and Collaborations

 

13. Funding and Investment Analysis

 

14. Antibody Discovery Services: Market Forecast

 

15. Antibody Discovery Technologies: Market Forecast

 

16. Case in Point: Drug Discovery Processes of Top Selling Antibodies

 

17. Case Study: Antibody Humanization and Affinity Maturation

 

18. Future Growth Opportunities

 

19. Executive Insights

 

20. Concluding Remarks

 

21. Appendix 1: Tabulated Data

 

22. Appendix 2: List of Companies and Organizations

 

 

PressRelease: Variation 3 (Format 4)

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/antibody-discovery-services-and-platforms/213.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com